Evidence mapPaperPMID 37559411Full record

ReviewEndocrine reviews2024

Obesity-Related Hypogonadism in Women.

Pei Chia Eng, Maria Phylactou, Ambreen Qayum, Casper Woods, Hayoung Lee, Sara Aziz, Benedict Moore, Alexander D Miras, Alexander N Comninos, Tricia Tan and 3 more

Open access · hybridAbstract readReview
In one paragraph

Review in Endocrine reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Anti-Müllerian hormone and somatic ovarian function: a new perspective.Journal of assisted reproduction and genetics · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Pei Chia EngSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.ORCID 0000-0002-4172-1344
Maria PhylactouSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Ambreen QayumSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Casper WoodsSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Hayoung LeeSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Sara AzizSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Benedict MooreSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Alexander D MirasSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Alexander N ComninosSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Tricia TanSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.ORCID 0000-0001-5873-3432
Steve FranksSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Waljit S DhilloSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
Ali AbbaraSection of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.ORCID 0000-0003-2795-5256
Imperial College Healthcare NHS Trust · GBImperial College London · GBNational University of Singapore · SG

Funding

Imperial Clinical Research FacilityMRCNIHRUK Department of HealthUK National Health Service
6 · The paper itself

Abstract

Obesity-related hypogonadotropic hypogonadism is a well-characterized condition in men (termed male obesity-related secondary hypogonadism; MOSH); however, an equivalent condition has not been as clearly described in women. The prevalence of polycystic ovary syndrome (PCOS) is known to increase with obesity, but PCOS is more typically characterized by increased gonadotropin-releasing hormone (GnRH) (and by proxy luteinizing hormone; LH) pulsatility, rather than by the reduced gonadotropin levels observed in MOSH. Notably, LH levels and LH pulse amplitude are reduced with obesity, both in women with and without PCOS, suggesting that an obesity-related secondary hypogonadism may also exist in women akin to MOSH in men. Herein, we examine the evidence for the existence of a putative non-PCOS "female obesity-related secondary hypogonadism" (FOSH). We précis possible underlying mechanisms for the occurrence of hypogonadism in this context and consider how such mechanisms differ from MOSH in men, and from PCOS in women without obesity. In this review, we consider relevant etiological factors that are altered in obesity and that could impact on GnRH pulsatility to ascertain whether they could contribute to obesity-related secondary hypogonadism including: anti-Müllerian hormone, androgen, insulin, fatty acid, adiponectin, and leptin. More precise phenotyping of hypogonadism in women with obesity could provide further validation for non-PCOS FOSH and preface the ability to define/investigate such a condition.

Indexed as

HypogonadismPolycystic Ovary SyndromeAndrogensFemaleFollicle Stimulating HormoneGonadotropin-Releasing HormoneHumansLuteinizing HormoneMaleObesityAndrogensFollicle Stimulating HormoneGonadotropin-Releasing HormoneLuteinizing Hormone

Identifiers

PMID37559411
PMCPMC10911953
OpenAlexW4385715184

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.